A handheld sensor and innovative technique developed by Texas A&M AgriLife Research scientists could one day offer a noninvasive alternative to food diaries and blood tests when monitoring diet and health.
Natural killer (NK) cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research from the University of Texas MD Anderson Cancer Center.
https://medicalxpress.com/news/2025-08-mechanism-cognitive-disorders-schizophrenia.html
Scientists at St. Jude Children’s Research Hospital demonstrated for the first time that the protein midkine plays a preventative role against Alzheimer’s disease.
As we age, our cells replicate, and the DNA in these cells can acquire mistakes—or mutations—every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance toward cancer development later in life.
Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have collaborated with partners at Greifswald University Hospital and University Medical Center Rostock to demonstrate that cold plasma can effectively combat tumor cells even in deeper tissue layers.
Boston Scientific (NYSE: BSX)+
announced today that it initiated a new trial to assess its Agent DCB compared to the standard of care.